Is Broadcom Stock Now a Better Buy Than Nvidia?

The article argues Nvidia remains the better AI chip investment versus Broadcom, citing faster overall revenue growth of 85% year over year in Nvidia's fiscal Q1 2027 versus Broadcom's 48% and a much cheaper forward P/E for Nvidia. Broadcom's AI semiconductor revenue grew 143% and management projected 200% growth next quarter, but the piece emphasizes that Nvidia still has stronger industry positioning and superior valuation. The content is primarily comparative analysis and should have limited direct market impact.

Analysis

The market is treating this as a relative-value debate, but the bigger second-order effect is that AVGO’s custom silicon push validates demand fragmentation inside AI infrastructure. That is constructive for the whole compute stack: hyperscalers want lower unit economics and more control, which should keep capex flowing even if some training workloads migrate away from merchant GPUs. The near-term loser is not NVDA’s business model, but its pricing power at the margin if buyers now have a credible negotiation anchor.

NVDA still screens as the cleaner compounder because it monetizes the entire software-hardware ecosystem, while AVGO’s AI upside is more concentrated and execution-dependent. The key risk is that the market may be underestimating how quickly custom silicon revenues can scale once a hyperscaler design wins a second and third deployment cycle; that creates a multi-quarter narrative shift, not a one-quarter trade. Conversely, the consensus may be overreacting to AVGO’s pullback without fully discounting that its AI growth is still earlier in the S-curve and therefore more sensitive to order timing and customer concentration.

From a positioning standpoint, the setup favors owning NVDA on dips and using AVGO only as a higher-beta satellite. Any disappointment in GPU supply, gross margin mix, or capex cadence would hurt NVDA first in the next 1-2 quarters, but over 6-18 months the more important variable is whether hyperscalers diversify enough to compress the premium multiple. That keeps the pair trade nuanced: AVGO can outperform on incremental design-win headlines even if NVDA remains the structurally better business.

Key Decisions for Investors

• Long NVDA / short AVGO as a 6-12 month relative-value trade: NVDA should retain premium quality and earnings visibility, while AVGO’s upside is more execution-sensitive; use a 1:1 dollar-neutral structure and reassess if AVGO prints additional hyperscaler design wins.
• Buy NVDA on any 5-8% pullback over the next 2-6 weeks; risk/reward favors buying the leader when the market is debating share capture, with downside limited by ecosystem lock-in and upside tied to continued AI capex cadence.
• Sell AVGO out-of-the-money calls against a core long if already held, targeting the next 1-2 earnings windows; this monetizes elevated sentiment while acknowledging that custom-chip enthusiasm can fade if guidance normalizes.
• For higher-beta exposure, use AVGO call spreads rather than stock over the next 3-6 months; payoff is strongest if the market starts capitalizing custom silicon as a durable second AI platform, but outright equity carries valuation and concentration risk.
• Monitor hyperscaler capex commentary next quarter as the key catalyst; if cloud budgets inflect lower, de-risk both names, but especially AVGO, because its custom-chip thesis depends on a few large customers sustaining spend.